FDA Seeking Public Comments on Cannabidiol (CBD) | NORML
WASHINGTON, DC — The US Food and Drug Administration (FDA) is soliciting public comments with regard to the therapeutic utility and abuse liability of various substances, including cannabidiol (CBD). The agency will consider these comments prior to preparing a formal response to the World Health Organization, which is considering placing the substances within their international drug scheduling code. Cannabidiol is defined by […]
FDA Seeking Public Comments on Cannabidiol (CBD) | The Daily Chronic
Leave a Reply